Ⅰ類主要組織相容性復合體E(MHCE)多克隆抗體
Polyclonal Antibody to Major Histocompatibility Complex Class I E (MHCE)
HLAE; EA1.2; EA2.1; HLA-6.2; MHC-E; HLA-E; Leukocyte Antigen E; MHC class I antigen E; HLA class I histocompatibility antigen, alpha chain E
- 編號PAB752Hu01
- 物種Homo sapiens (Human，人)相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPB752Hu01-Ⅰ類主要組織相容性復合體E(MHCE)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度0.5mg/mL
- 且適物種Mus musculus (Mouse，小鼠)
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術，請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 598¥ 1394¥ 1992¥ 4980¥ 19920
- 欲了解實際交易價格和更多情況，請與當?shù)亟?jīng)銷商聯(lián)系!
產(chǎn)品包裝(模擬)
產(chǎn)品包裝(模擬)
DAB staining on IHC-P; Sample: Mouse Uterus Tissue Primary Ab: 10μg/ml Rabbit Anti-Human MHCE Antibody Control: Used PBS instead of primary antibody Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
DAB staining on IHC-P;
Sample: Mouse Liver Tissue
Primary Ab: 10μg/ml Rabbit Anti-Human MHCE Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
DAB staining on IHC-P;
Sample: Mouse Spleen Tissue
Primary Ab: 10μg/ml Rabbit Anti-Human MHCE Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
AF488 staining on IF;
Sample: Raji cell
Primary Ab: 20μg/ml Rabbit Anti-Human MHCE Antibody
Second Ab: 2μg/ml AF488-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb11)
Figure. Western Blot; Sample: Recombinant MHCE, Human.
Western Blot; Samples: Lane1: THP1 cell lysate; Lane2: Raji cell lysate; Lane3: Ramos cell lysate; Lane4: HUVEC cell lysate;
Primary Ab: 0.3μg/ml Rabbit Anti-Human MHCE Antibody
Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody
(Catalog: SAA544Rb19)
通過ISO 9001、ISO 13485質量體系認證
特異性
該抗體是針對MHCE的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別MHCE。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質期內(nèi)，在適當?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務
相關產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| RPB752Hu01 | Ⅰ類主要組織相容性復合體E(MHCE)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAB752Hu01 | Ⅰ類主要組織相容性復合體E(MHCE)多克隆抗體 | WB; IHC; ICC; IP. |
| MAB752Hu22 | Ⅰ類主要組織相容性復合體E(MHCE)單克隆抗體 | WB; IHC; ICC; IP. |
| SEB752Hu | Ⅰ類主要組織相容性復合體E(MHCE)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMB752Hu | Ⅰ類主要組織相容性復合體E(MHCE)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| Arthritis & Rheumatism | HLA–E gene polymorphism associated with susceptibility to kawasaki disease and formation of coronary artery aneurysms[Asia: source] |
| International Journal of Rheumatic Diseases | Soluble-HLA-E: A follow up biomarker in Takayasu arteritis, independent of HLA-E genotype[pubmed:28425192] |
| SCHIZOPHRENIA BULLETIN | Immune signatures of treatment resistant schizophrenia: a FACE-SZ study[] |
| Sci Rep | HLA-E circulating and genetic determinants in schizophrenia and bipolar disorder[34642395] |